Prostate Cancer: Markers IIPD65-07 ISOPSA™: INTERIM CLINICAL PERFORMANCE EVALUATION OF A NOVEL STRUCTURE-BASED BIOMARKER FOR PROSTATE CANCER IN A MULTICENTER PROSPECTIVE TRIAL FOR GLEASON ≥7